Fahy J V, Schuster A, Ueki I, Boushey H A, Nadel J A
Cardiovascular Research Institute, University of California, San Francisco 94143-0130.
Am Rev Respir Dis. 1992 Dec;146(6):1430-3. doi: 10.1164/ajrccm/146.6.1430.
To investigate the role of neutrophil proteases in the pathogenesis of mucus hypersecretion in bronchiectasis, we collected sputum samples from seven patients with bronchiectasis and measured their secretagogue activity by examining secretion of radiolabeled macromolecules by bovine airway submucosal gland cells incubated with sputum supernatants. There was marked secretagogue activity in bronchiectasis sputum, reaching a maximum of 1,963 +/- 292% (mean +/- SEM) above baseline at 1:15 dilution. Addition of ICI 200,355 (10(-5) M), a selective human neutrophil elastase inhibitor, decreased the secretory response markedly (72.53 +/- 5.89% reduction). The combination of aprotinin, an inhibitor of cathepsin G, and ICI 200,355 caused significantly more reduction in the secretory response than ICI 200,355 alone (89.12 +/- 3.8 versus 72.53 +/- 5.89% reduction, p < 0.05). We conclude that bronchiectasis sputum causes a large secretory response from tracheal submucosal glands due mostly to neutrophil proteases.
为了研究中性粒细胞蛋白酶在支气管扩张症黏液分泌过多发病机制中的作用,我们收集了7例支气管扩张症患者的痰液样本,并通过检测与痰液上清液孵育的牛气道黏膜下腺细胞分泌放射性标记大分子的情况来测定其促分泌活性。支气管扩张症痰液中存在显著的促分泌活性,在1:15稀释时,其活性比基线水平最高增加了1,963±292%(平均值±标准误)。加入选择性人中性粒细胞弹性蛋白酶抑制剂ICI 200,355(10⁻⁵ M)可显著降低分泌反应(降低72.53±5.89%)。组织蛋白酶G抑制剂抑肽酶与ICI 200,355联合使用导致的分泌反应降低幅度明显大于单独使用ICI 200,355(分别降低89.12±3.8%和72.53±5.89%,p<0.05)。我们得出结论,支气管扩张症痰液主要通过中性粒细胞蛋白酶引起气管黏膜下腺的大量分泌反应。